Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting
Go back to Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting| (NASDAQ: IMTX) | Delayed: 9.38 +0.32 (3.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.06 | 52 Week High | $ | |||
| Open | $9.08 | 52 Week Low | $ | |||
| Day High | $9.48 | P/E | N/A | |||
| Day Low | $9.05 | EPS | $ | |||
| Volume | 376,663 | |||||

